FluoroPharma Announces Completion of Merger and Fu... (the cellular and molecular levels. Fluor...)

FluoroPharma Announces Completion of Merger and Fund Raising

Date:5/18/2011

the cellular and molecular levels. FluoroPharma is advancing two products in clinical trials for assessment of acute and chronic forms of coronary disease. These agents have been designed to rapidly target myocardial cell activity and inflamed plaques within the coronary arteries.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward looking statements in this news release include statements regarding FluoroPharma's research and development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as significant fluctuations in expenses associated with clinical trials, failure to secure additional financing, the inability to complete regulatory filings with the Food and Drug Administration, the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in FluoroPharma's filings with the United States Securities and Exchange Commission. FluoroPharma undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE FluoroPharma
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
2. FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
3. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
4. FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
5. Concord Medical Announces First Quarter 2011 Financial Results
6. Medco Announces Webcast for Annual Meeting of Shareholders
7. University Hospitals Seidman Cancer Center Announces $30 Million Proton Therapy Center
8. CryoLife Announces Completion of Acquisition of Cardiogenesis
9. NeoStem Announces Agreement with Nankai Hospital in Tianjin to Offer NeoStems Licensed Orthopedic Technology
10. HASCO Medical Announces Acquisition of Mobility Freedom Inc. and Wheelchair Vans of America
11. InspireMD Announces Year-to-Date 2011 Progress

Post Your Comments:

(Date:5/20/2013)... National Community Pharmacists Association (NCPA) CEO ... issued the following statement today regarding a survey ... "preferred pharmacy" drug plans , which often exclude ... advertised co-payments: (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ... MedPAC , 16 U.S. Senators and more ...

(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- Today at American Society for ... Ginocchio discussed Specific Technologies blood culture ... of microorganisms producing bloodstream infection. Dr. Ginocchio is ... Division of Infectious Disease Diagnostics at North Shore-LIJ ... health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ) ...

(Date:5/20/2013)... Hill-Rom Holdings, Inc. (NYSE: HRC ) ... the 38 th Annual Deutsche Bank Health Care ... 30, 2013, at 1:30 p.m. EDT. (Logo: ... to listen to the live discussion via the internet ... at http://www.media-server.com/m/p/f7bj3q84 . A recorded replay of the ...

Breaking Medicine Technology:Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2 Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3 Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4 Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2 Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3

[0] Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans [0] Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio [0] Hill-Rom to Participate in the 38th Annual Deutsche Bank Health Care Conference

... ANN ARBOR, Mich., Feb. 6, 2012 Adeona Pharmaceuticals, Inc. ... synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious ... Director appointments to strengthen and expand the Company,s leadership, ... of the Adeona Board of Directors since March 2010 ...

... Feb. 6, 2012 EntreMed, Inc. (Nasdaq: ENMD ), ... cancer, announced today that Wei-Wu He, Ph.D has joined the ... Ph.D has joined as a member of the Board of ... Dr. Wei-Wu He is currently the CEO and Chairman of ...

Cached Medicine Technology:Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biologics Strategic Focus 2 Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biologics Strategic Focus 3 Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biologics Strategic Focus 4 Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biologics Strategic Focus 5 Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors 2 Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors 3 Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors 4

Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biologics Strategic Focus Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors

(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Thousands of ... from the lung condition known as chronic obstructive ... that patients placed on the common antibiotic azithromycin ... due to flare-ups of the disease. "Given ... of such events is critical," said Victoria Richards, ...

(Date:5/21/2013)... PHILADELPHIA The surgical management of non-small cell lung ... the race of the patient, according to a new ... I and Stage II NSCLC is surgery," said researcher ... in Omaha, Nebraska. "In our study of more than ... the years 2000 and 2010, we found statistically significant ...

(Date:5/21/2013)... Clinical measurement of physical activity appears to be ... with chronic obstructive pulmonary disease (COPD) will end ... conducted by researchers in Connecticut. The study also ... of inactivity with an increased incidence of hospitalizations ... the study will be presented at the ATS ...

(Date:5/21/2013)... PHILADELPHIA─Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a ... breakdown and protects the lung,s elasticity, is effective ... with Alpha-1 antitrypsin deficiency (AATD), a life-threatening genetic ... the 2013 American Thoracic Society International Conference. , ... the loss of lung tissue as measured by ...

(Date:5/21/2013)... 2013 Barbara Michels, author of “ ... over 50 years of experience in the world of ... both her mom and dad to Alzheimer’s disease ... volunteer with the New Mexico Chapter of the Alzheimer’s ... and insight into the many challenges caregivers experience. Through ...

Breaking Medicine News(10 mins):Health News:Long-Term Use of Antibiotic May Help Those With COPD 2 Health News:Long-Term Use of Antibiotic May Help Those With COPD 3 Health News:Exercise levels may predict hospitalizations in COPD population 2 Health News:Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency 2 Health News:Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency 3 Health News:International Book Release on Alzheimer’s Care-giving by Barbara Michels “The Alzheimer’s Journey…A Practical Perspective for Caregivers 2 Health News:International Book Release on Alzheimer’s Care-giving by Barbara Michels “The Alzheimer’s Journey…A Practical Perspective for Caregivers 3 Health News:International Book Release on Alzheimer’s Care-giving by Barbara Michels “The Alzheimer’s Journey…A Practical Perspective for Caregivers 4

[0] Long-Term Use of Antibiotic May Help Those With COPD [0] Racial disparities in the surgical management of non-small cell lung cancer [0] Exercise levels may predict hospitalizations in COPD population [0] Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency [0] International Book Release on Alzheimer’s Care-giving by Barbara Michels “The Alzheimer’s Journey…A Practical Perspective for Caregivers

... It,s the time of year when more,than 1.5 million ... up the sun and drink large quantities of alcohol. Students ... as much as,those who stay home with parents or relatives, ... Journal of Studies on Alcohol and Drugs., Instead of ...

... to request more aggressive therapy, study finds , , TUESDAY, ... can help predict the risk of cancer recurrence in ... therapy, a new U.S. study says. , Researchers from ... review of MRI images taken before 80 prostate cancer ...

... Professional Marketing Inc. also assessed civil penalty of,$512,000, ... Inc. (APMI), a medical staffing company based in ... have been charged by the U.S.,Department of Labor ... that authorize employers to bring non-immigrant workers,into the ...

... Cancer Center will open a Phase I pancreatic ... leading researchers from Israel, marking the first time ... counterparts in Israel. , The study is ... Bi-National Industrial Research and Development Foundation (BIRDF). Leaders ...

... Top 1 Million for First Time, ARLINGTON ... of cosmetic plastic surgery procedures were performed,on ethnic ... year, including,Hispanics, African Americans and Asian Americans, according ... Plastic Surgeons (ASPS)., Since 2006, cosmetic plastic ...

... Tiered Copayments, Generics, and the,Mail-Service Pharmacy Option to ... new survey of,employers that finds the utilization of ... cost of prescription drug benefits highlights the,value of ... savings,and access for payors and consumers, the Pharmaceutical ...

Cached Medicine News:Health News:It's Spring Break: How Much Does Heavy Drinking Affect Your Body? 2 Health News:MRI Can Be Predictor of Post-Treatment Prostate Cancer Spread 2 Health News:New York City Staffing Company Charged With Violating H-1B Program Following U.S. Labor Department Finding Almost $3 Million in Back Wages Due 156 Workers 2 Health News:VCU Massey Cancer Center to partner with Israeli biotech firm 2 Health News:VCU Massey Cancer Center to partner with Israeli biotech firm 3 Health News:Cosmetic Plastic Surgery Procedures for Ethnic Patients up 13 Percent in 2007 2 Health News:Employers: Proven PBM Tools Slowing Cost of Prescription Drug Benefits 2

It's Spring Break: How Much Does Heavy Drinking Affect Your Body?MRI Can Be Predictor of Post-Treatment Prostate Cancer Spread New York City Staffing Company Charged With Violating H-1B Program Following U.S. Labor Department Finding Almost $3 Million in Back Wages Due 156 Workers VCU Massey Cancer Center to partner with Israeli biotech firm Cosmetic Plastic Surgery Procedures for Ethnic Patients up 13 Percent in 2007 Employers: Proven PBM Tools Slowing Cost of Prescription Drug Benefits

Long-Sleeve Bolero for targeted compression in the upper arms, upper back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....

Velcro® closure, uniform contour compression, available as 9" and 12" bands for abdominal support, 9" can be used as a breast wrap....

Sub Pectoral Breast Augmentation Wrap...

CDIs Ultra-Comfort Bra™ is designed with special single needle stitching that places the cup seams away from critical surgical sites....

Medicine Products:

Long-Sleeve Bolero Diamond Wear™ Abdominal Band/Breast Wrap Sub Pectoral Breast Augmentation Wrap Ultra-Comfort Surgical Bra™